In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Mahdi, T.
	Articles by Kitzis, A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Mahdi, T.
	Articles by Kitzis, A.


Social Bookmarking

	What's this?

Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. and Vogelstein, B (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.[Abstract/Free Full Text]

Bodine, D. M., Seidel, N. E., Zsebo, K. M. and Orlic, D (1993). In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82, 445-455.[Abstract/Free Full Text]

Bookstein, R., Shew, J. Y., Chen, P. L., Scully, P. and Lee, W. H (1990). Suppression of tumorigenicity of human prostate carcima cells by replacing a mutated RB gene. Science 247, 712-715.[Abstract/Free Full Text]

Brandt, J., Baird, N., Lu, L., Srour, E. and Hoffman, R (1988). Characterization of a human hematopoietic progenitor cell capable of forming blast cells containing colonies in vitro. J. Clin. Invest 82, 1017-1027.

Cardoso, A. A., Li, M.-L., Batard, P., Hatzfeld, A., Brown, E. L., Levesque, J.-P., Sookdeo, H., Panterne., B. Sansilvestri, P., Clark, S. C. and Hatzfeld, J (1993). Release from quiescence of CD34+CD38human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Nat. Acad. Sci. USA 90, 8707-8711.[Abstract/Free Full Text]

Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C. and Nevins, J. R (1992). Adenovirus E1A, siman virus 40tumor antigen, and human papilloma virus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Nat. Acad. Sci. USA 89, 4549-4553.[Abstract/Free Full Text]

Debili, N., Masse, J.-M., Katz, A., Guichard, J., Breton-Gorius, J. and Vainchenker, W (1993). Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+cells. Blood 82, 84-95.[Abstract/Free Full Text]

Delwiche, F., Raines, E., Powell, J., Ross, R. and Adamson, J (1985). Platelet derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells. J. Clin. Invest 76, 137-142.

Diller, L., Kassel, J., Nelson, C. E., Gryka, M., Litwak, G., Gebhardt, M., Bressac, B., Ozturc, M., Baker, S. J., Vogelstein, B. and Friend, S. H (1990). p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell Biol 10, 5772-5781.[Abstract/Free Full Text]

Duhersen, U., Villeval, J.-L., Boyd, J., Kannourakis, G., Morstyn, G., Metcalf, D (1988). Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72, 2074-2080.[Abstract/Free Full Text]

Dyson, N., Howley, P. M., Munger, K. and Harlow, E (1989). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.[Abstract/Free Full Text]

Eaves, C. J (1993). Peripheral blood stem cells reach new heights. Blood 82, 1957-1959.[Free Full Text]

Eaves, C. J., Cashman, J. D., Wolpe S. D. and Eaves, A. C (1993). Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1a, an inhibitor of primitive normal hematopoietic cells. Proc. Nat. Acad. Sci. USA 90, 12015-12019.[Abstract/Free Full Text]

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.[Medline]

Fung, Y. K., T'Ang, A., Murphree, A. L., Zhang, F. H., Qiu, W. R., Wang, S. W., Shi, X. H., Lee, L., Driscoll, B. and Wu, K, J (1993). The Rb gene suppresses the growth of normal cells. Oncogene 8, 2659-2672.[Medline]

Gannon, J. V. and Lane, D. P (1991). Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature, 349, 802-806.[Medline]

Gewirtz, A. M., Xu, W. Y. and Morgan, K. F (1987). Role of natural killer cells in comparaison with T-lymphocytes and monocytes, in the regulation of normal human megakaryocytosis in vitro. J. Immunol 139, 2915-2924.[Abstract]

Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A. C., Pileri, A. and Bonadonna, G (1989). Granulocyte-macrophage colony stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2, 580-585.[Medline]

Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.[Medline]

Harris, C. C. and Hollstein, M (1993). The clinical implications of p53 tumor suppressor gene. New Eng. J. Med 329, 1318-1327.[Free Full Text]

Hatzfeld, J., Li, M.-L., Brown, E. L., Sookedo, H., Levesque, J.-P., O'Toole., Gurney, C., Clark, S. C. and Hatzfeld, A (1991). Release of early hematopoietic progenitors from quiescence by antisense transforming growth factor b1 or Rb oligonucleotides. J. Exp. Med 174, 925-929.[Abstract/Free Full Text]

Haylock, D. N., To, L.B., Dowse, T. L., Juttner, C.A., Simmons, P. J (1992). Ex vivo expansion and maturation of peripheral blood CD34+cells into the myeloid lineage. Blood 80, 1405-1412.[Abstract/Free Full Text]

Huang, H.-J. S., Yee, J. K., Shew, J. Y., Chen, P. L., Bookstein, R., Friedmann, T., Lee, E. Y.-H. P. and Lee, W. H (1988). Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563-1566.[Abstract/Free Full Text]

Ikebuchi, K., Ihle, J. N., Hiari, Y., Wong, G. G., Clark, S. C. and Ogawa, M (1988). Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6 and granulocyte colony-stimulating factor. Blood 72, 2007-2014.[Abstract/Free Full Text]

Issaad, C., Croisille, L., Katz, A., Vainchenker, W. and Coulombel. L (1993). A murine stromal cell line allows the proliferation of very primitive human CD34+/CD38progenitor cells in long-term cultures and semi-solid assays. Blood 81, 2916-2924.[Abstract/Free Full Text]

Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B (1991). Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.[Abstract/Free Full Text]

Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V. and Kastan, M. B (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Nat. Acad. Sci. USA 89, 7491-7495.[Abstract/Free Full Text]

Liu, X., Miller, C. W. and Koeffler, P. H.and Berk A. J (1993). The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell Biol 13, 3291-3300.[Abstract/Free Full Text]

Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S. and Neckers, L. M (1989). Characterization of oligonucleotide transport into living cells. Proc. Nat. Acad. Sci. USA 86, 3474-3478.[Abstract/Free Full Text]

Lowe, S. W., Schmitt, E. M., Schmitt, S. W., Osborne, B. A. and Jacks, T (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849.[Medline]

Metcalf, D (1993). Hematopoietic regulators: redundancy or subtlety?. Blood 82, 3515-3523.[Free Full Text]

Michael, J. and Stillman, B (1993). Analysis of protein binding domain of p53. Mol. Cell Biol 13, 3811-3820.[Abstract/Free Full Text]

Mihara, K., Cao, X. R., Yen, A., Chandler, S., Driscoll, B., Murphree, A. L., T'Ang, A. and Fung, Y. T (1989). Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246, 1300-1303.[Abstract/Free Full Text]

Muncaster, M. M., Cohen, B. L., Phillips, R. A. and Gallie, B. L (1992). Failure of Rb1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res 52, 654-661.[Abstract/Free Full Text]

Nicola, N. A (1989). Hematopoietic growth factors and their receptors. Annu. Rev. Biochem 58, 45-77.[Medline]

Pietenpol, J. A. and Vogelstein, B (1993). Tumor suppressor genes. No room in p53 inn. Nature 365, 17-18.[Medline]

Sato, N., Sawada, K., Koizumi, K., Tarumi, T., Ieko, M., Yasukouchi, T., Yamaguchi, M., Takahashi, T. A., Sekiguchi, S. and Koike T (1993). In vitro expansion of human peripheral blood CD34+cells. Blood 82, 3600-3609.[Abstract/Free Full Text]

Skorski, T., Szczylik, C., Ratajczak, M. Z., Malaguarnera, L., Gewirtz, A. M. and Calabretta, B (1992). Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligonucleotides. J. Exp. Med 175, 743-750.[Abstract/Free Full Text]

Stirdivant, S. M., Huber, H. E., Patrick, D. R., Defeo-Jones, D., McAvoy, E. M., Garsky, V. M., Oliff, A. and Heimbrook, D. C (1992). Human papilloma hk virus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product. Mol. Cell. Biol 12, 1905-1914.[Abstract/Free Full Text]

Sturzbecher, H. W., Maimets, T., Chumakov, P., Brain, R., Addison, C., Simanis, V., Rudge, K., Philp, R., Grimaldi, M., Court, W. and Jenkins, J. R (1990). P53 interacts with p34cdc2in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene 5, 795-801.[Medline]

Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C. and Levine A. J (1992). Wilde-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev 6, 1143-1152.[Abstract/Free Full Text]

Zsebo, K. M., Wypych, J., McNiece, I. K., Lu, H. S., Smith, K. A., Karkare, S. B., Sachdev, R. K., Yuschenkoff, V. N., Birkett, N. C., Williams L. R., Satyagal V. N., Tung W., Bosselman, R. A., Mendiaz, E. A. and Langley K. E (1990). Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat-liver conditioned medium. Cell 63, 195-201.[Medline]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

P. G. Fuhrken, P. A. Apostolidis, S. Lindsey, W. M. Miller, and E. T. Papoutsakis
Tumor Suppressor Protein p53 Regulates Megakaryocytic Polyploidization and Apoptosis
J. Biol. Chem., June 6, 2008; 283(23): 15589 - 15600.
[Abstract] [Full Text] [PDF]

A. Shih, F. B. Davis, H.-Y. Lin, and P. J. Davis
Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1223 - 1232.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Mahdi, T.

Articles by Kitzis, A.

Search for Related Content

PubMed

PubMed Citation

Articles by Mahdi, T.

Articles by Kitzis, A.

Social Bookmarking

What's this?

				A. Shih, F. B. Davis, H.-Y. Lin, and P. J. Davis Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1223 - 1232. [Abstract] [Full Text] [PDF]